Insights

2 highly-rated ASX dividend shares named as buys

These dividend shares could be great options for income investors…
The post 2 highly-rated ASX dividend shares named as buys appeared first on The Motley Fool Australia. –

Are you looking for some top ASX dividend shares to add to your income portfolio next week?

If you are, you might want to look at the ones listed below. Here’s what you need to know about these highly rated dividend shares:

Accent Group Ltd (ASX: AX1)

The first ASX dividend share to look at is Accent. It is a retail group with a collection of popular footwear-focused store brands. These include stores such as HYPEDC, Platypus, and The Athlete’s Foot.

Accent certainly was on form in FY 2021. For the 12 months ended 30 June, the company reported a 19.9% increase in sales to $1.14 billion and a 38.6% jump in net profit after tax to $76.9 million.

Thanks to this strong form, the Accent Board was able to increase its full year dividend by 21.6% to 11.25 cents in FY 2021.

This went down well with the team at Bell Potter. In response to its results, the broker retained its buy rating but trimmed its price target to $2.90. The latter was due to its expectation that FY 2022’s result will be softer due to lockdowns.

Nevertheless, the broker remains positive on the future. Its team have pencilled in dividends per share of 9 cents in FY 2022 and 13 cents in FY 2023.

Based on the latest Accent share price of $2.19, this represents yields of 4.1% and 5.9%, respectively.

Sonic Healthcare Limited (ASX: SHL)

Another ASX dividend share to look at is Sonic Healthcare. It is a leading medical diagnostics company with operations across the world.

Over the last 30+ years Sonic has earned a reputation for excellence in pathology, diagnostic imaging, and primary care medical services. This is across operations spanning the ANZ, European and North American markets.

Sonic was also a very strong performer in FY 2021. Last month it delivered a 28% increase in revenue to $8.8 billion and a 149% lift in net profit to $1.3 billion. This was driven largely by strong demand for COVID-19 testing services.

Morgans is positive on the company and has an add rating and $45.98 price target on its shares. It is also forecasting dividends per share of 95 cents in FY 2022 and 99 cents in FY 2023. Based on the latest Sonic share price of $43.75, this will mean partially franked yields of 2.2% and 2.3%, respectively.

The post 2 highly-rated ASX dividend shares named as buys appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of August 16th 2021

More reading

Top broker tips Accent (ASX:AX1) share price to rise 33%
Top performing ASX 200 healthcare shares in August

Sonic Healthcare (ASX:SHL) share price struggles despite COVID passport positioning
3 top ASX results from week four of reporting season

Sonic Healthcare (ASX:SHL) share price hits record high at $43.43

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Accent Group and Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!